Aurora kinase inhibitors require PUMA to induce apoptosis and preferentially kill KRAS-mutant colon cancer cells

被引：0
|
作者：
Sun, Jing [1 ]
Knickelbein, Kyle [1 ]
He, Kan [1 ]
Chen, Dongshi [1 ]
Yu, Jian [1 ]
Zhang, Lin [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2577
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers
    Hata, Aaron N.
    Yeo, Alan
    Faber, Anthony C.
    Lifshits, Eugene
    Chen, Zhao
    Cheng, Katherine A.
    Walton, Zandra
    Sarosiek, Kristopher A.
    Letai, Anthony
    Heist, Rebecca S.
    Mino-Kenudson, Mari
    Wong, Kwok-Kin
    Engelman, Jeffrey A.
    [J]. CANCER RESEARCH, 2014, 74 (11) : 3146 - 3156
  • [22] BRAF inhibitors synergize with BH3 mimetics to induce apoptosis in BRAF mutant colorectal cancer cells
    Jenkins, Laura J.
    Chionh, Fiona
    Luk, Ian Y.
    Lee, Erinna F.
    Dhillon, Amardeep S.
    Tebbutt, Niall
    Fairlie, Walter D.
    Mariadason, John M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [23] Inhibition of hsp90 by auy922 preferentially kills mutant KRAS colon cancer cells by activating Bim through ER stress
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Yan, Xu Guang
    Farrelly, Margaret
    Zhang, Yuan Yuan
    Liu, Fen
    Yari, Hamed
    La, Ting
    Lei, Fu Xi
    Jin, Lei
    Jiang, Chen Chen
    Zhang, Xu Dong
    [J]. CANCER RESEARCH, 2017, 77
  • [24] Inhibition of HSP90 by AUY922 Preferentially Kills Mutant KRAS Colon Cancer Cells by Activating Bim through ER Stress
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Liu, Fen
    Zhang, Yuan Yuan
    Yari, Hamed
    Yan, Xu Guang
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (03) : 448 - 459
  • [25] MEK inhibitors and DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, prevent the migration and invasion of KRAS-mutant cancer cells
    Matsuda, Aoi
    Masuzawa, Ryuichi
    Takahashi, Kazuya
    Takano, Kazunori
    Endo, Takeshi
    [J]. CYTOSKELETON, 2024,
  • [26] Author Correction: Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin
    Xiao-ming Huang
    Jia-jun Huang
    Jing-jing Du
    Na Zhang
    Ze Long
    You Yang
    Fang-fang Zhong
    Bo-wen Zheng
    Yun-fu Shen
    Zhe Huang
    Xiang Qin
    Jun-he Chen
    Qian-yu Lin
    Wan-jun Lin
    Wen-zhe Ma
    [J]. Acta Pharmacologica Sinica, 2022, 43 : 1881 - 1881
  • [27] Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells
    Hadi, Loubna Abdel
    Di Vito, Clara
    Marfia, Giovanni
    Ferraretto, Anita
    Tringali, Cristina
    Viani, Paola
    Riboni, Laura
    [J]. PLOS ONE, 2015, 10 (11):
  • [28] Sulindac metabolites induce apoptosis in colon cancer cells by selectively downregulating the MAP kinase arm of EGF receptor signaling
    Kraus, HM
    Rice, P
    Ahnen, D
    Walczak, H
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A264 - A265
  • [29] mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells
    N Komatsu
    Y Fujita
    M Matsuda
    K Aoki
    [J]. Oncogene, 2015, 34 : 5607 - 5616
  • [30] Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth
    Hilliard, Tyvette S.
    Gaisina, Irina N.
    Muehlbauer, Amanda G.
    Gaisin, Arsen M.
    Gallier, Franck
    Burdette, Joanna E.
    [J]. ANTI-CANCER DRUGS, 2011, 22 (10) : 978 - 985
12345